The global Liquid Biopsy Market was valued at USD 1746.9 Million in 2022 and is projected to experience a revenue CAGR of 20.7% throughout the forecast period. Factors such as the increasing prevalence of cancer, advancements in clinical trials and initiatives, and growing investments in healthcare have been instrumental in driving the revenue growth of the global liquid biopsy market. One of...